<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231025059853N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-14</date_registration>
      <primary_sponsor>Shahre-kord University of Medical Sciences</primary_sponsor>
      <public_title>Comparative evaluation of the efficacy of calcium hydroxide with resin modified glass ionomer versus TheraCal in indirect pulp cap: a clinical trial study</public_title>
      <acronym></acronym>
      <scientific_title>Comparative evaluation of the efficacy of calcium hydroxide with resin modified glass ionomer versus TheraCal in indirect pulp cap in teeth with deep caries: a clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73349</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method of replacement blocks will be used with the size of each block equal to 6. The randomization list will be prepared by the permutation block method using Allcation Random software and will be provided to the researcher, Blinding description: This clinical trial study will be conducted in a double-blind manner so that both the patients participating in the study and the statistical analyst will be blinded.
Blinding for the patients will be in such a way that theracal and calcium hydroxide materials have similar colors and the patients will not have any information about the content of the received intervention.
Also, the information file will be provided to the statistical analyst in the form of group A and group B, and this person will not have any information about the content of the intervention of groups A and B, which will cause all the results to be analyzed based on groups A and B and will be provided to the main researcher.</study_design>
      <phase>3</phase>
      <hc_freetext>Indirect pulp capping for teeth with deep decay.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: People treated with TheraCal : For both intervention and control groups, local anesthesia, isolation of the investigated tooth and selective removal of caries are performed. The tooth is disinfected with chlorhexidine 2% and rinsed with normal saline. Then the teeth are randomly divided into two groups: the intervention group consists of 25 teeth and will be treated with TheraCal LC (calcium silicate liner modified with light cure resin): the material is applied to the deepest points of the cavity floor and It is then light cured according to the manufacturer's instructions. TheraCal LC from Bisco is supplied by the manufacturer as a disposable syringe and syringe head and does not require preparation before use. Intervention 2: Control group: people treated with self cure calcium hydroxide (Dycal) and light cure hybrid ionomer liner: Dycal is available as a two-paste system (a catalyst paste and a base paste). Equal amounts of catalyst and base are mixed and applied with a Dycal applicator directly to the deepest points of dentin in the cavity. Excess Dycal material will be removed from the cavity walls and enamel margins. Then Light Cure glass ionomer cement is placed in the cavity as a base.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The clinical study report will be published as an article

When:
It is possible to start accessing immediately after printing the results

To whom:
Access is open to the public

Conditions:
For more information

Where to obtain:
Fadak Complex, Hamedanian St. ,Hasht Behesht St. ,Isfahan
Shamim Mohammadi
khorshid_mohammad@yahoo.com
09134432263

How to obtain:
The clinical study report will be available to the public immediately after printing. For detailed information, send an email to 
khorshid_mohammad@yahoo.com.
The data files will reach the applicant after 1 month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shamim Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fadak complex,hamedanian st., hasht behesht st., Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8157967764</zip>
        <telephone>+98 31 3270 9327</telephone>
        <email>khorshid_mohammad@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shamim Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Fadak complex,hamedanian st., hasht behesht st., Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8157967764</zip>
        <telephone>+98 31 3270 9327</telephone>
        <email>khorshid_mohammad@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with mature permanent teeth with closed apex
Patients with caries in the dentin more than one-half or three-quarters of the thickness of the dentin
Patients with reversible pulpitis
Dental samples must respond positively to the cold test</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with irreversible pulpitis
Teeth with internal and external absorption
Tooth with periapical lesion
Tooth with necrotic pulp
Cracked teeth
People with periodontitis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K02.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Caries of dentine</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: People treated with TheraCal : For both intervention and control groups, local anesthesia, isolation of the investigated tooth and selective removal of caries are performed. The tooth is disinfected with chlorhexidine 2% and rinsed with normal saline. Then the teeth are randomly divided into two groups: the intervention group consists of 25 teeth and will be treated with TheraCal LC (calcium silicate liner modified with light cure resin): the material is applied to the deepest points of the cavity floor and It is then light cured according to the manufacturer's instructions. TheraCal LC from Bisco is supplied by the manufacturer as a disposable syringe and syringe head and does not require preparation before use.</i_keyword>
      <i_keyword>Control group: people treated with self cure calcium hydroxide (Dycal) and light cure hybrid ionomer liner: Dycal is available as a two-paste system (a catalyst paste and a base paste). Equal amounts of catalyst and base are mixed and applied with a Dycal applicator directly to the deepest points of dentin in the cavity. Excess Dycal material will be removed from the cavity walls and enamel margins. Then Light Cure glass ionomer cement is placed in the cavity as a base.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The degree of pain or clinical sensitivity. Timepoint: 21 days, three months and six months after treatment. Method of measurement: Based on the Numeric Rating Scale.</prim_outcome>
      <prim_outcome>Vitality of the pulp or Vitality of the dental nerve, which is determined by the feeling of cold or heat after performing vitality tests. Timepoint: 21 days, three months and six months after treatment. Method of measurement: Vitality tests (cold and heat test).</prim_outcome>
      <prim_outcome>Widening of the periodontal ligament space around the apex in radiographs. Timepoint: 6 months after treatment in case of pain and clinical sensitivity. Method of measurement: Radiography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahre-kord University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-13</approval_date>
        <contact_name>Research Ethics Committees of School of Medicine - Shahrekord University of Medical Sciences</contact_name>
        <contact_address>Fadak complex,Hamedanian St.,East Haht Behesht St. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
